A Phase 2 Study to Evaluate the Safety and Efficacy of KZR-616 in Patients With AIHA and ITP
Public ClinicalTrials.gov record NCT04039477. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Randomized, Dose-blind, Multicenter Study to Evaluate the Safety and Efficacy of KZR-616 in the Treatment of Patients With Autoimmune Hemolytic Anemia (AIHA) and Immune Thrombocytopenia (ITP)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 2 randomized, dose-blind, multicenter study designed to evaluate the safety, tolerability, efficacy, Pharmacokinetics (PK), and Pharmacodynamics (PD) of treatment with KZR-616 in patients with active Autoimmune Hemolytic Anemia or Immune Thrombocytopenia.
Study identification
- NCT ID
- NCT04039477
- Recruitment status
- Withdrawn
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- Not listed
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2020 (Estimated)
- Primary completion
- Aug 5, 2020 (Actual)
- Completion
- Aug 5, 2020 (Actual)
- Last update posted
- Aug 7, 2020
2020
United States locations
- U.S. sites
- 15
- U.S. states
- 10
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| KZR Research Site | Los Angeles | California | 90007 | — |
| KZR Research Site | San Francisco | California | 94143 | — |
| KZR Research Site | Jacksonville | Florida | 32224 | — |
| KZR Research Site | Miami Lakes | Florida | 33014 | — |
| KZR Research Site | Tampa | Florida | 33612 | — |
| KZR Research Site | Peoria | Illinois | 61615 | — |
| KZR Research Site | Boston | Massachusetts | 02114 | — |
| KZR Research Site | Minneapolis | Minnesota | 55454 | — |
| KZR-616 Research Site | Rochester | Minnesota | 55455 | — |
| KZR Research Site | Morristown | New Jersey | 07960 | — |
| KZR Research Site | The Bronx | New York | 10467 | — |
| KZR Research Site | Greenville | North Carolina | 27834 | — |
| KZR Research Site | Cleveland | Ohio | 44195 | — |
| KZR Research Site | Columbus | Ohio | 43210 | — |
| KZR Research Site | Webster | Texas | 77598 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04039477, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 7, 2020 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04039477 live on ClinicalTrials.gov.